NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
Show detailsBibliographic details: Savarese G, Musella F, Volpe M, Paneni F, Perrone-Filardi P. Effects of atorvastatin and rosuvastatin on renal function: a meta-analysis. International Journal of Cardiology 2013; 167(6): 2482-2489. [PubMed: 22633671]
Abstract
BACKGROUND: Atorvastatin (A) and rosuvastatin (R) are highly effective and widely used statins. However, conflicting results have been reported regarding their renal effects. The aim of the present study was to compare the effects of A and R on glomerular filtration rate (GFR) and new onset proteinuria in patients at high cardiovascular risk.
METHODS: Randomized trials about A or R treatments reporting clinical end-points were included in the meta-analysis. Influence of both treatments on GFR and new onset proteinuria was assessed.
RESULTS: 23 trials enrolling 29,147 participants were included. A significant reduction in GFR was detected in placebo-treated compared to statin-treated patients (standard mean difference [SMD]: 0.056, 95% confidence interval [CI]:0.028 to 0.083, p<0.01). In particular, a significant reduction in GFR was detected in placebo as compared to either R-treated (SMD: 0.052, CI: 0.022 to 0.081, p=0.001) or A-treated patients (SMD: 0.084, CI: 0.008 to 0.161, p=0.031). No significant difference in GFR was detected in 5 head-to-head studies comparing A to R (SMD: 0.043, CI: -0.041 to 0.126, p=0.319). In 9 studies comparing A to R, R treatment significantly increased the risk of proteinuria when compared to A (odds ratio [OR]: 0.656, CI: 0.440 to 0.977, p=0.038, heterogeneity p=0.026), but this effect was no longer significant when studies using highest therapeutic doses of R (40 mg/daily) were excluded from analysis, abolishing significant heterogeneity (OR: 1.505, CI: 0.827 to 2.739, p=0.181).
CONCLUSIONS: A and R show similar reno-protective effects in patients at high cardiovascular risk, with comparable rates of new onset proteinuria when commonly used doses are considered.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
- Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.[Clin Ther. 2004]Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group. Clin Ther. 2004 Nov; 26(11):1821-33.
- Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.[Am J Cardiol. 2008]Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.Wlodarczyk J, Sullivan D, Smith M. Am J Cardiol. 2008 Dec 15; 102(12):1654-62. Epub 2008 Sep 20.
- Effects of rosuvastatin and atorvastatin on renal function: meta-analysis.[Circ J. 2012]Effects of rosuvastatin and atorvastatin on renal function: meta-analysis.Wu Y, Wang Y, An C, Dong Z, Liu H, Zhang Y, Zhang M, An F. Circ J. 2012; 76(5):1259-66. Epub 2012 Mar 1.
- Review A meta-analysis of randomized head-to-head trials for effects of rosuvastatin versus atorvastatin on apolipoprotein profiles.[Am J Cardiol. 2014]Review A meta-analysis of randomized head-to-head trials for effects of rosuvastatin versus atorvastatin on apolipoprotein profiles.Takagi H, Umemoto T, ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Am J Cardiol. 2014 Jan 15; 113(2):292-301. Epub 2013 Oct 3.
- Review Effects of rosuvastatin versus atorvastatin on small dense low-density lipoprotein: a meta-analysis of randomized trials.[Heart Vessels. 2014]Review Effects of rosuvastatin versus atorvastatin on small dense low-density lipoprotein: a meta-analysis of randomized trials.Takagi H, Niwa M, Mizuno Y, Yamamoto H, Goto SN, Umemoto T. Heart Vessels. 2014 May; 29(3):287-99. Epub 2013 May 5.
- Effects of atorvastatin and rosuvastatin on renal function: a meta-analysis - Da...Effects of atorvastatin and rosuvastatin on renal function: a meta-analysis - Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews
Your browsing activity is empty.
Activity recording is turned off.
See more...